Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Journal of Nuclear Medicine Supplement summarizes current molecular radiotherapy


Supplement projects future possibilities and partnering with patients in providing care

A special supplement to the Society of Nuclear Medicine’s Journal of Nuclear Medicine examines current and future uses of radionuclide therapy and its importance in medical practice and patient management.

Supplement editors Steven M. Larson, M.D., and Eric P. Krenning, M.D., Ph.D., present a comprehensive overview intended to offer relevant advice to nuclear medicine practitioners and other professionals who may be actively involved in radionuclide therapy and to provide them with a summary of suggested patterns of practice for common radionuclide therapies now available. They also include a forecast of the near-term opportunities that are likely to determine practice in the next few years.

Radionuclide therapy is an important and increasingly significant component of modern medical practice for a growing number of patients with thyroid cancer, lymphoma, metastatic bone involvement with prostate and breast cancer and carcinoid tumors, explained Larson, who is chief of nuclear medicine at Memorial Sloan-Kettering Cancer Center, New York, N.Y. Larson and Eric P. Krenning, M.D., Ph.D., Erasmus University Medical Center, Rotterdam, the Netherlands, are guest editors for the 204-page volume of "Clinical Practice of Molecular Radiotherapy," released in January.

In their introduction, Larson and Krenning note, "More and more, interested patients and their families will become partners in care in radionuclide therapy." To illustrate this and other points, the editors chose a dramatic photo for the cover symbolizing an important segment of the treatment population--women with thyroid cancer--one that has the distinction of being the most rapidly increasing in incidence in this country. "Nuclear medicine will play a growing role in the care of thyroid cancer and other tumors in the future," Larson said. Larson and Krenning also draw attention to the importance of cancer survivor groups in setting policy and promoting cancer awareness.

This essential resource includes the introduction, "A Pragmatic Perspective on Molecular Targeted Radionuclide Therapy," along with 26 articles (including black and white and color images) addressing future applications, conventional therapies, tumor-seeking peptides in therapy and tumor-seeking monoclonal antibodies. Articles include "Radiobiologic Principles in Radionuclide Therapy"; "The Evolving Role of 131I for the Treatment of Differentiated Thyroid Carcinoma"; "Bone-Seeking Radionuclides for Therapy"; "Radiosynovectomy in Rheumatology, Orthopedics and Hemophilia"; "Candidates for Peptide Receptor Radiotherapy Today and in the Future"; "Perspectives on Cancer Therapy With Radiolabeled Monoclonal Antibodies"; "The Promise of Immuno-PET in Radioimmunotherapy"; "Radiotargeted Gene Therapy"; and "Radiation Sensitizers: A Selective Review of Molecules Targeting DNA and non-DNA Targets."

"This supplement offers significant information for nuclear/molecular imaging professionals and deserves a place in your professional library," notes Heinrich R. Schelbert, M.D., Ph.D., editor of the Journal of Nuclear Medicine. JNM is the most prominent peer-reviewed journal in nuclear medicine, molecular imaging and allied disciplines. Not only does JNM rank among the top imaging journals, its impact factor puts it in the top 5 percent of all scientific serials rated by the Institute for Scientific Information. Published monthly, JNM features clinical investigations and basic science papers, continuing education articles, book reviews, an event calendar and an employment section.

Maryann Verrillo | EurekAlert!
Further information:

More articles from Health and Medicine:

nachricht Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg

nachricht New potential cancer treatment using microwaves to target deep tumors
12.10.2016 | University of Texas at Arlington

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Seeking balanced networks: how neurons adjust their proteins during homeostatic scaling.

24.10.2016 | Life Sciences

Resolving the mystery of preeclampsia

21.10.2016 | Health and Medicine

Stanford researchers create new special-purpose computer that may someday save us billions

21.10.2016 | Information Technology

More VideoLinks >>>